FDA’s Lab Test Power-Grab Continues
More FDA protectionism that works against patient interests. Action Alert! The FDA has announced its intent to issue a proposed rule this coming August that would extend the agency’s power over laboratory developed tests (LDTs). This is a critical threat, as LDTs are crucial tools used in personalized medicine because labs can create custom diagnostic […]